text: <unk>  is an antibiotic of the cephalosporin type (third generation), licensed for use in veterinary medicine. It was first described in 1987. It is marketed by pharmaceutical company Pfizer as Excede.
  It is resistant to the antibiotic resistance enzyme beta-lactamase, and has activity against Gram-positive and Gram-negative bacteria. E. coli strains resistant to<unk>  have been reported.
option_0: Ceftiofur
option_1: Gemifloxacin mesylate
option_2: Trovafloxacin mesylate
option_3: Balofloxacin
option_4: Prulifloxacin
option_5: Cethromycin
option_6: Moxifloxacin 
option_7: Amikacin sulfate